Phoenix Biotech Acquisition Corp. (PBAXU) ist ein börsennotiertes Unternehmen im Finanzdienstleistungen Sektor, tätig in der Shell Companies Branche. Der Hauptsitz des Unternehmens ist in Oakland, CA, United States. Der aktuelle CEO ist Christopher B. Ehrlich.
PBAXU hat IPO-Datum 2021-10-06, gelistet an der NASDAQ Global Market, eine Marktkapitalisierung von $36.54M.
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, California.
